Diabetic Care Market Merger and Acquisitions , Drivers, Restraints and Industry Forecast By 2027

Increasing diabetic population, rising awareness about diabetes treatment and management, and favourable government initiatives are some key factors driving market revenue growth

The latest report is the most recent study that offers 360° coverage of the Diabetic Care industry that has been facing the brunt of the adverse economic impact of the COVID-19 outbreak since the beginning of this year. The global health crisis has affected nearly every aspect of the business vertical and led to massive disruptions to the global Diabetic Care market demand and supply chains. Researchers draw predictions for the market scenario in the post-COVID era. The report, additionally, assesses the present market situation and estimates its future outcomes, keeping in mind the impact of the pandemic on the global economic landscape.

However, significant shortage of trained professional worldwide and challenges related to management of diabetes, including a lack of general awareness about diabetes and its complications among a sizable number of younger individuals, especially in remote areas are key factors expected to restrain revenue growth of the Global Diabetes Care Market to some extent.

Get a Free sample of the report : https://www.emergenresearch.com/request-sample/180

Emergen Research has segmented Global Diabetes Care Market on the basis of device type, distribution type, end-use, and region:

Device Type Outlook (Revenue, USD Million; 2018–2028)

  • Blood Glucose Monitoring
    • Self-Monitoring Devices
      1. Blood Glucose Meters
      2. Test Strips
      3. Lancelets
    • Continuous Glucose Monitoring Devices
      1. Sensors
      2. Transmitters
      3. Receiver
  • Insulin Delivery Devices
    1. Pumps
    2. Pens
    3. Syringes
    4. Jet Injectors

By Distribution Channel Outlook (Revenue, USD Million; 2018–2028)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

End-use Outlook (Revenue, USD Million; 2018–2028)

  • Hospitals Clinics
  • Homecare Settings
  • Diagnostic Centers

Segmental Analysis

The global Diabetic Care market is broadly segmented on the basis of different product types, application range, end-use industries, key regions, and an intensely competitive landscape. This section of the report is solely targeted at readers looking to select the most appropriate and lucrative segments of the Diabetic Care sector in a strategic manner. The segmental analysis also helps companies interested in this sector make optimal business decisions and achieve their desired goals.

Request customization of the report: https://www.emergenresearch.com/request-for-customization/180

Some Key Highlights from the Report

Based on device type, the market is segmented into blood glucose monitoring devices and insulin delivery devices (pumps, pens, syringes, and jet injectors). Blood glucose monitoring devices segment is further sub-segmented into self-monitoring devices (blood glucose meters, testing strips, and lancets) and continuous glucose monitoring devices (sensors, transmitters and receivers). The blood glucose monitoring devices segment accounted for largest share in 2020 and the trend is expected to continue over the forecast period.

On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment dominated other distribution segments in the global market and accounted for the largest revenue share in 2020 owing to high demand and availability of diabetic care products. The two types of pharmacies operating within a hospital campus are inpatient pharmacy and outpatient pharmacy, and footfalls to hospitals is relatively high for diabetes.

Some major companies in the market report include Medtronic plc (Ireland), B. Braun (Germany), DexCom, Inc. (US), Abbott (US), F. Hoffman-La Roche Ltd. (Switzerland), Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Sanofi (France), Terumo Corporation, Ypsomed (Switzerland), Dr. Morepen (India), Insulet, Life Scan IP holdings, and Eli Lilly and Company

In May 2021, Medtronic announced that it had received a CE mark for its InPen smart insulin pen and Guardian 4 sensor for better diabetes management.

Regional Analysis of the Diabetic Care Market:

  • North America (U.S., Canada)
  • Europe (U.K., Italy, Germany, France, Rest of EU)
  • Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
  • Latin America (Chile, Brazil, Argentina, Rest of Latin America)
  • Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Rapid Business Growth Factors

In addition, the market is growing at a fast pace and the report shows us that there are a couple of key factors behind that. The most important factor that’s helping the market grow faster than usual is the tough competition.

Let us know if you have any specific requirements. We offer report customization.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe, MEA or Asia Pacific.

Key Points of Diabetic Care Market:

Extensive coverage of the analysis of the Diabetic Care market

Key insights into the regional spread of the industry in key geographies

Radical insights into the vital market trends; both current and emerging trends, and factors influencing the growth of the market

Comprehensive coverage of the impact of the COVID-19 pandemic on the overall growth of the Diabetic Care market

Complete data about the key manufacturers and vendors in the Diabetic Care market

 

Read More: https://www.emergenresearch.com/industry-report/diabetic-care-market

Related reports:

biologics market

https://www.google.com.ai/url?q=https://www.emergenresearch.com/industry-report/biologics-market

clinical decision support systems market

https://www.google.com.ai/url?q=https://www.emergenresearch.com/industry-report/clinical-decision-support-systems-cdss-market

recurrent atrial fibrillation market

https://www.google.com.ai/url?q=https://www.emergenresearch.com/industry-report/recurrent-atrial-fibrillation-market

chronic rhinosinusitis market

https://www.google.com.ai/url?q=https://www.emergenresearch.com/industry-report/chronic-rhinosinusitis-market

pharmacovigilance market

https://www.google.com.ai/url?q=https://www.emergenresearch.com/industry-report/pharmacovigilance-market

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

 

 


karan

9 Blog posts

Comments